POA Pharma focusses on the distribution, marketing, and commercialisation of proprietary, generic, and rare disease medication through a commercial infrastructure across Europe. We are a specialty pharmaceutical company with expertise in several therapeutic areas across the Nordics and Germany. At POA pharma, we are committed to do all we can to improve the lives and benefit the health of all generations affected by a variety of diseases. POA Pharma is part of Galen Limited, a privately owned company established in 1968, with global headquarters in Craigavon, Northern Ireland, and commercial operations based in the UK, Ireland, the Nordics, Europe, and the USA. POA was founded in Northern Ireland in 1968 by the late Sir Allen McClay (d. 2010), the revered philanthropist and entrepreneur. POA Pharma’s focus is selling medicines worldwide and are committed to customer care and partner with like-minded companies to accomplish this. By combining innovation in product development with competitive pricing, we work together, in partnership with healthcare professionals and patients to create real, long-term value, a major factor in our success to date. Our expertise lies in: • sales, marketing and launch excellence • market access • regulatory affairs, pharmacovigilance and medical affairs • supply chain and logistics.
